This self-perpetuating loop of MMP-9 expression after tPA administration may explain why higher levels of MMP-9 expression predict more severe intracranial hemorrhage with thrombolytic treatment in human stroke (Montaner et al., 2003). This evidence concerns the gene MMP9 and stroke disorder.